The New York State SARS-CoV-2 Testing Consortium: Regional Communication in Response to the COVID-19 Pandemic

James M. Crawford, Maria E. Aguero-Rosenfeld, Ioannis Aifantis, Evan M. Cadoff, Joan F. Cangiarella, Carlos Cordon-Cardo, Melissa Cushing, Aldolfo Firpo-Betancourt, Amy S. Fox, Yoko Furuya, Sean Hacking, Jeffrey Jhang, Debra G.B. Leonard, Jenny Libien, Massimo Loda, Damadora Rao Mendu, Mark J. Mulligan, Michel R. Nasr, Nicole D. Pecora, Melissa S. PessinMichael B. Prystowsky, Lakshmi V. Ramanathan, Kathleen R. Rauch, Scott Riddell, Karen Roach, Kevin A. Roth, Kenneth R. Shroyer, Bruce R. Smoller, Steven L. Spitalnik, Eric D. Spitzer, John E. Tomaszewski, Susan Waltman, Loretta Willis, Zeynep Sumer-King

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Abstract

The COVID-19 pandemic, caused by severe acute respiratory syndrome coronavirus 2, created an unprecedented need for comprehensive laboratory testing of populations, in order to meet the needs of medical practice and to guide the management and functioning of our society. With the greater New York metropolitan area as an epicenter of this pandemic beginning in March 2020, a consortium of laboratory leaders from the assembled New York academic medical institutions was formed to help identify and solve the challenges of deploying testing. This report brings forward the experience of this consortium, based on the real-world challenges which we encountered in testing patients and in supporting the recovery effort to reestablish the health care workplace. In coordination with the Greater New York Hospital Association and with the public health laboratory of New York State, this consortium communicated with state leadership to help inform public decision-making addressing the crisis. Through the length of the pandemic, the consortium has been a critical mechanism for sharing experience and best practices in dealing with issues including the following: instrument platforms, sample sources, test performance, pre- and post-analytical issues, supply chain, institutional testing capacity, pooled testing, biospecimen science, and research. The consortium also has been a mechanism for staying abreast of state and municipal policies and initiatives, and their impact on institutional and laboratory operations. The experience of this consortium may be of value to current and future laboratory professionals and policy-makers alike, in dealing with major events that impact regional laboratory services.

Original languageEnglish (US)
JournalAcademic Pathology
Volume8
DOIs
StatePublished - 2021
Externally publishedYes

Keywords

  • advocacy
  • communication
  • laboratory
  • public health
  • supply chain

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Fingerprint

Dive into the research topics of 'The New York State SARS-CoV-2 Testing Consortium: Regional Communication in Response to the COVID-19 Pandemic'. Together they form a unique fingerprint.

Cite this